Oxaprozin Capsule
Product Images NDC 70512-787

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oxaprozin (NDC 70512-787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sola Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxa (Oxaprozin Label)

This text provides important information about storing oxaprozin capsules, dosage, and NDC number. It mentions storing the capsules at room temperature between 20°C to 25°C, with excursions permitted between 18°C to 30°C. It also advises protecting the capsules from light and dispensing them in tight, light-resistant, child-resistant containers. Each capsule contains 300 mg of oxaprozin and the manufacturer is SOLA Pharmaceuticals, LLC. The NDC number is 70512-787-60. Additionally, it recommends always dispensing with the Medication Guide.*

FDA Label Image

Pic (Picture1)

This segment provides pharmacokinetic parameters for Oxaprozin in healthy adults aged 28 to 60 years after a 600 mg dose. Values include Conax (85.144 ug/mL), Tmax (3.00 hours), and AUC0-72 (2939.697 ug-h/mL). Conax represents the concentration, Tmax indicates the time of maximum concentration, and AUC0-72 is the area under the concentration curve from 0 to 72 hours.*

FDA Label Image

Cs (Chemicalstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.